» Articles » PMID: 34526912

Optogenetic Stimulation Using Anion Channelrhodopsin (GtACR1) Facilitates Termination of Reentrant Arrhythmias With Low Light Energy Requirements: A Computational Study

Overview
Journal Front Physiol
Date 2021 Sep 16
PMID 34526912
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Optogenetic defibrillation of hearts expressing light-sensitive cation channels (e.g., ChR2) has been proposed as an alternative to conventional electrotherapy. Past modeling work has shown that ChR2 stimulation can depolarize enough myocardium to interrupt arrhythmia, but its efficacy is limited by light attenuation and high energy needs. These shortcomings may be mitigated by using new optogenetic proteins like Anion Channelrhodopsin (GtACR1), which produces a repolarizing outward current upon illumination. Accordingly, we designed a study to assess the feasibility of GtACR1-based optogenetic arrhythmia termination in human hearts. We conducted electrophysiological simulations in MRI-based atrial or ventricular models ( = 3 each), with pathological remodeling from atrial fibrillation or ischemic cardiomyopathy, respectively. We simulated light sensitization via viral gene delivery of three different opsins (ChR2, red-shifted ChR2, GtACR1) and uniform endocardial illumination at the appropriate wavelengths (blue, red, or green light, respectively). To analyze consistency of arrhythmia termination, we varied pulse timing (three evenly spaced intervals spanning the reentrant cycle) and intensity (atrial: 0.001-1 mW/mm; ventricular: 0.001-10 mW/mm). In atrial models, GtACR1 stimulation with 0.005 mW/mm green light consistently terminated reentry; this was 10-100x weaker than the threshold levels for ChR2-mediated defibrillation. In ventricular models, defibrillation was observed in 2/3 models for GtACR1 stimulation at 0.005 mW/mm (100-200x weaker than ChR2 cases). In the third ventricular model, defibrillation failed in nearly all cases, suggesting that attenuation issues and patient-specific organ/scar geometry may thwart termination in some cases. Across all models, the mechanism of GtACR1-mediated defibrillation was voltage forcing of illuminated tissue toward the modeled channel reversal potential of -40 mV, which made propagation through affected regions impossible. Thus, our findings suggest GtACR1-based optogenetic defibrillation of the human heart may be feasible with ≈2-3 orders of magnitude less energy than ChR2.

Citing Articles

Theoretical analysis of low-power deep synergistic sono-optogenetic excitation of neurons by co-expressing light-sensitive and mechano-sensitive ion-channels.

Roy S, Pyari G, Bansal H Commun Biol. 2025; 8(1):379.

PMID: 40050670 PMC: 11885482. DOI: 10.1038/s42003-025-07792-8.


Computational modeling of cardiac electrophysiology and arrhythmogenesis: toward clinical translation.

Trayanova N, Lyon A, Shade J, Heijman J Physiol Rev. 2023; 104(3):1265-1333.

PMID: 38153307 PMC: 11381036. DOI: 10.1152/physrev.00017.2023.


Optogenetic Modulation of Arrhythmia Triggers: Proof-of-Concept from Computational Modeling.

Ochs A, Boyle P Cell Mol Bioeng. 2023; 16(4):243-259.

PMID: 37810996 PMC: 10550900. DOI: 10.1007/s12195-023-00781-z.


Recent advances and current limitations of available technology to optically manipulate and observe cardiac electrophysiology.

Marchal G, Biasci V, Yan P, Palandri C, Campione M, Cerbai E Pflugers Arch. 2023; 475(11):1357-1366.

PMID: 37770585 PMC: 10567935. DOI: 10.1007/s00424-023-02858-0.


Optogenetically mediated large volume suppression and synchronized excitation of human ventricular cardiomyocytes.

Pyari G, Bansal H, Roy S Pflugers Arch. 2023; 475(12):1479-1503.

PMID: 37415050 DOI: 10.1007/s00424-023-02831-x.


References
1.
Elnakish M, Canan B, Kilic A, Mohler P, Janssen P . Effects of zacopride, a moderate I channel agonist, on triggered arrhythmia and contractility in human ventricular myocardium. Pharmacol Res. 2016; 115:309-318. PMC: 5234043. DOI: 10.1016/j.phrs.2016.11.033. View

2.
Bishop M, Rodriguez B, Eason J, Whiteley J, Trayanova N, Gavaghan D . Synthesis of voltage-sensitive optical signals: application to panoramic optical mapping. Biophys J. 2006; 90(8):2938-45. PMC: 1414570. DOI: 10.1529/biophysj.105.076505. View

3.
Boyle P, Karathanos T, Entcheva E, Trayanova N . Computational modeling of cardiac optogenetics: Methodology overview & review of findings from simulations. Comput Biol Med. 2015; 65:200-8. PMC: 4591100. DOI: 10.1016/j.compbiomed.2015.04.036. View

4.
Entcheva E . Cardiac optogenetics. Am J Physiol Heart Circ Physiol. 2013; 304(9):H1179-91. PMC: 3652095. DOI: 10.1152/ajpheart.00432.2012. View

5.
Bruegmann T, Malan D, Hesse M, Beiert T, Fuegemann C, Fleischmann B . Optogenetic control of heart muscle in vitro and in vivo. Nat Methods. 2010; 7(11):897-900. DOI: 10.1038/nmeth.1512. View